Agilent Technologies (NYSE:A) VP Rodney Gonsalves sold 6,825 shares of the business’s stock in a transaction that occurred on Tuesday, March 13th. The stock was sold at an average price of $71.23, for a total value of $486,144.75. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
A traded down $2.03 during trading on Friday, hitting $63.65. The company’s stock had a trading volume of 3,256,639 shares, compared to its average volume of 2,321,138. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.78 and a current ratio of 3.23. The company has a market capitalization of $21,180.22, a PE ratio of 26.97, a price-to-earnings-growth ratio of 2.18 and a beta of 1.31. Agilent Technologies has a twelve month low of $52.31 and a twelve month high of $75.00.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.08. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same period in the previous year, the firm posted $0.53 EPS. equities research analysts forecast that Agilent Technologies will post 2.7 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 25th. Stockholders of record on Tuesday, April 3rd will be paid a dividend of $0.149 per share. The ex-dividend date is Monday, April 2nd. This represents a $0.60 annualized dividend and a dividend yield of 0.94%. Agilent Technologies’s dividend payout ratio is presently 25.42%.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Dupont Capital Management Corp purchased a new stake in shares of Agilent Technologies during the 3rd quarter valued at $101,000. Front Row Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at $106,000. Compagnie Lombard Odier SCmA purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at $126,000. AMG National Trust Bank purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at $201,000. Finally, Premia Global Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at $204,000.
Several research analysts recently issued reports on A shares. ValuEngine upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. JPMorgan Chase lifted their price objective on Agilent Technologies from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Barclays restated a “buy” rating and set a $74.00 price objective on shares of Agilent Technologies in a research report on Monday, January 8th. Evercore ISI started coverage on Agilent Technologies in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price objective for the company. Finally, Robert W. Baird restated a “buy” rating and set a $76.00 price objective on shares of Agilent Technologies in a research report on Thursday, January 18th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $72.48.
COPYRIGHT VIOLATION NOTICE: “Rodney Gonsalves Sells 6,825 Shares of Agilent Technologies (NYSE:A) Stock” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.dispatchtribunal.com/2018/04/07/rodney-gonsalves-sells-6825-shares-of-agilent-technologies-inc-a-stock.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.